267 related articles for article (PubMed ID: 27059685)
1. Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.
Wimmer NJ; Secemsky EA; Mauri L; Roe MT; Saha-Chaudhuri P; Dai D; McCabe JM; Resnic FS; Gurm HS; Yeh RW
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003464. PubMed ID: 27059685
[TBL] [Abstract][Full Text] [Related]
2. Arterial access-site complications after use of a vascular closure device related to puncture height.
Sartorius B; Behnes M; Ünsal M; Hoffmann U; Lang S; Mashayekhi K; Borggrefe M; Akin I
BMC Cardiovasc Disord; 2017 Feb; 17(1):64. PubMed ID: 28209184
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society.
Farooq V; Goedhart D; Ludman P; de Belder MA; Harcombe A; El-Omar M;
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27225421
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population.
Kerré S; Kustermans L; Vandendriessche T; Bosmans J; Haine SE; Miljoen H; Vrints CJ; Beutels P; Wouters K; Claeys MJ
EuroIntervention; 2014 Jun; 10(2):191-7. PubMed ID: 24952056
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
Andrade PB; Mattos LA; Rinaldi FS; Bienert IC; Barbosa RA; Labrunie A; Tebet M; Esteves V; Abizaid A; Sousa AR
Catheter Cardiovasc Interv; 2017 May; 89(6):976-982. PubMed ID: 27514319
[TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized trial comparing the effectiveness and safety of a novel vascular closure device to manual compression in anticoagulated patients undergoing percutaneous transfemoral procedures: The CELT ACD trial.
Wong SC; Laule M; Turi Z; Sanad W; Crowley J; Degen H; Bennett K; Coleman JE; Bergman G
Catheter Cardiovasc Interv; 2017 Nov; 90(5):756-765. PubMed ID: 28296003
[TBL] [Abstract][Full Text] [Related]
7. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial.
Rao SV; Hess CN; Barham B; Aberle LH; Anstrom KJ; Patel TB; Jorgensen JP; Mazzaferri EL; Jolly SS; Jacobs A; Newby LK; Gibson CM; Kong DF; Mehran R; Waksman R; Gilchrist IC; McCourt BJ; Messenger JC; Peterson ED; Harrington RA; Krucoff MW
JACC Cardiovasc Interv; 2014 Aug; 7(8):857-67. PubMed ID: 25147030
[TBL] [Abstract][Full Text] [Related]
8. Transfemoral approach with systematic use of FemoSeal™ closure device compared to transradial approach in primary angioplasty.
Alonzo A; Rigattieri S; Giovannelli F; Di Russo C; Sciahbasi A; Berni A; Volpe M
Catheter Cardiovasc Interv; 2016 Apr; 87(5):849-54. PubMed ID: 26104978
[TBL] [Abstract][Full Text] [Related]
9. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.
Tavris DR; Wang Y; Jacobs S; Gallauresi B; Curtis J; Messenger J; Resnic FS; Fitzgerald S
J Invasive Cardiol; 2012 Jul; 24(7):328-34. PubMed ID: 22781471
[TBL] [Abstract][Full Text] [Related]
10. Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era: a comparative study.
Theodos G; Raymond C; Becker MC; Thornton J; Ellis SG; Bhatt DL; Raymond RE
Catheter Cardiovasc Interv; 2013 Feb; 81(2):294-300. PubMed ID: 22826017
[TBL] [Abstract][Full Text] [Related]
11. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
[TBL] [Abstract][Full Text] [Related]
12. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012).
Feldman DN; Swaminathan RV; Kaltenbach LA; Baklanov DV; Kim LK; Wong SC; Minutello RM; Messenger JC; Moussa I; Garratt KN; Piana RN; Hillegass WB; Cohen MG; Gilchrist IC; Rao SV
Circulation; 2013 Jun; 127(23):2295-306. PubMed ID: 23753843
[TBL] [Abstract][Full Text] [Related]
13. Comparison of collagen-based vascular closure devices in patients with vs. without severe peripheral artery disease.
Kara K; Kahlert P; Mahabadi AA; Plicht B; Lind AY; Longwitz D; Bollow M; Erbel R
J Endovasc Ther; 2014 Feb; 21(1):79-84. PubMed ID: 24502487
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.
Xhepa E; Byrne RA; Schulz S; Helde S; Gewalt S; Cassese S; Linhardt M; Ibrahim T; Mehilli J; Hoppe K; Grupp K; Kufner S; Böttiger C; Hoppmann P; Burgdorf C; Fusaro M; Ott I; Schneider S; Hengstenberg C; Schunkert H; Laugwitz KL; Kastrati A;
EuroIntervention; 2014 Jun; 10(2):198-203. PubMed ID: 24952057
[TBL] [Abstract][Full Text] [Related]
15. Contemporary Use and Outcomes of Arterial Closure Devices After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Prouse A; Gunzburger E; Yang F; Morrison J; Valle JA; Armstrong EJ; Waldo SW
J Am Heart Assoc; 2020 Feb; 9(4):e015223. PubMed ID: 32063086
[TBL] [Abstract][Full Text] [Related]
16. Safety of transradial access compared to transfemoral access with hemostatic devices (vessel plugs and suture devices) after percutaneous coronary interventions: A systematic review and meta-analysis.
Chugh Y; Bavishi C; Mojadidi MK; Elgendy IY; Faillace RT; Brilakis ES; Tamis-Holland J; Mamas M; Chugh SK
Catheter Cardiovasc Interv; 2020 Aug; 96(2):285-295. PubMed ID: 32521099
[TBL] [Abstract][Full Text] [Related]
17. Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
Khambatta S; Othman H; Seth M; Lalonde T; Rosman HS; Gurm HS; Mehta RH;
Cardiovasc Revasc Med; 2016 Jun; 17(4):233-40. PubMed ID: 26994504
[TBL] [Abstract][Full Text] [Related]
18. The CLOSER trial: a multi-center study on the clinical safety and effectiveness of Closer
Wong SC; Gammon R; Bachinsky W; O'Shaughnessy C; Leimbach W; Bernardo N; Cavros N; Jaff MR; Liu PY; Bergman G
Catheter Cardiovasc Interv; 2017 Nov; 90(5):798-805. PubMed ID: 28833996
[TBL] [Abstract][Full Text] [Related]
19. Comparison of manual compression and vascular hemostasis devices after coronary angiography or percutaneous coronary intervention through femoral artery access: A meta-analysis of randomized controlled trials.
Dahal K; Rijal J; Shahukhal R; Sharma S; Watti H; Azrin M; Katikaneni P; Jimenez E; Tandon N; Modi K; Lee J
Cardiovasc Revasc Med; 2018 Mar; 19(2):151-162. PubMed ID: 28941744
[TBL] [Abstract][Full Text] [Related]
20. Differential Use and Impact of Bleeding Avoidance Strategies on Percutaneous Coronary Intervention-Related Bleeding Stratified by Predicted Risk.
Gluckman TJ; Wang L; Spinelli KJ; Petersen JL; Huang P; Amin A; Messenger JC; Rao SV
Circ Cardiovasc Interv; 2020 Jun; 13(6):e008702. PubMed ID: 32527190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
